Harmonex — Dothan, Alabama

Harmonex is a clinical research site located in Dothan, Alabama, United States 36303.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Harmonex has participated in 9 clinical trials with 1 currently active.

Therapeutic areas: Attention Deficit Disorder With Hyperactivity, Attention-Deficit/Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD).

Sponsors: Lexicor Medical Technology, LLC, Purdue Pharma LP, Alcobra Ltd..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dothan

Browse all research sites in Alabama · View every site in Dothan

• Flowers Hospital
• Triad of Alabama/Flowers Hospital
• Harmonex Neuroscience Research
• Digestive Health Specialists of the Southeast
• Research Site
• GSK Investigational Site
• Trinity Research Group
• Digestive Health Specialists
• SEC Clinical Research
• Southeastern Pediatric Associates
• Eye Center South

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Harmonex?

Harmonex has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Harmonex conducted?

Harmonex has 9 clinical trials on record, with 1 currently active. Their work covers Attention Deficit Disorder With Hyperactivity, Attention-Deficit/Hyperactivity Disorder, Attention Deficit Hyperactivity Disorder (ADHD).

Is Harmonex accredited by Crixeo Clinical Trials?

Harmonex has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Harmonex?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.